Epithalon and Dihexa represent two distinct classes of synthetic peptides evaluated in preclinical cellular longevity and neurobiological research. While Epithalon functions primarily as a pineal-derived peptide bioregulator targeting telomerase expression, Dihexa operates as a potent c-Met receptor agonist involved in synaptogenesis.
Epithalon and Dihexa represent two distinct classes of synthetic peptides evaluated in preclinical cellular longevity and neurobiological research. While Epithalon functions primarily as a pineal-derived peptide bioregulator targeting telomerase expression, Dihexa operates as a potent c-Met receptor agonist involved in synaptogenesis.
Epithalon and Dihexa differ fundamentally in primary biological targets, molecular structure, and downstream signaling pathways. Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide bioregulator studied for telomerase activation, telomere length maintenance, and pineal gland modulation. In contrast, Dihexa is a hexapeptide derivative designed as a small-molecule c-Met receptor agonist evaluated primarily for spinogenesis, synaptogenesis, and neurodegenerative research models.
While both compounds attract significant interest in preclinical cellular aging protocols, their modes of action do not directly overlap. Researchers evaluating genomic stability, chromatin organization, and neuroendocrine rhythms typically select Epithalon. Conversely, investigators exploring dendritic spine formation, hepatocyte growth factor (HGF) mimetic activity, and cognitive loss repair pathways focus on Dihexa.
To assist laboratory personnel in protocol selection, the physical, chemical, and mechanistic parameters of both compounds are compared below:
| Specification Parameter | Epithalon (Epitalon) | Dihexa (PNB-0408) | | :--- | :--- | :--- | | **Mechanistic Class** | Synthetic Peptide Bioregulator | Angiotensin IV Analog / HGF Mimetic | | **Primary Receptor Target** | Chromatin / Epigenetic DNA Interaction | c-Met Receptor (Tyrosine Kinase) | | **Molecular Weight** | 390.35 g/mol | 508.65 g/mol | | **Reported In Vitro Half-Life** | Short (~15–30 minutes in plasma) | Moderately Stable (High metabolic stability) | | **Solubility Profile** | Water-soluble (Aqueous buffers / PBS) | Lipophilic / Soluble in DMSO or Acetic Acid | | **Primary Preclinical Model** | Cell senescence assays, Rodent longevity | Neuronal culture, Cognitive deficit models | | **Vial Sizes Available** | 10 mg, 20 mg, 50 mg | 10 mg, 20 mg |
When planning assays, researchers must account for these chemical differences. Epithalon dissolves rapidly in sterile bacteriostatic water or PBS, whereas Dihexa often requires specialized organic solvents or tailored solubilization agents prior to dilution into cell culture media. Researchers can explore our complete research peptide catalog for available formats.
Epithalon (also known as Epitalon) is a short-chain tetrapeptide with the amino acid sequence L-alanyl-L-glutamyl-L-aspartyl-glycine. Originally modeled after the naturally occurring bovine pineal gland extract epithalamin, Epithalon acts as a site-specific peptide bioregulator. In vitro and rodent studies indicate that Epithalon interacts directly with chromatin, binding to specific promoter regions of DNA to alter gene expression patterns.
The primary locus of Epithalon research focuses on its ability to upregulate telomerase (TERT) gene expression. Telomerase is the ribonucleoprotein enzyme responsible for extending telomeric tandem repeats (TTAGGG) at the terminal ends of eukaryotic chromosomes. Preclinical evidence suggests that by inducing telomerase expression in somatic human somatic cells, Epithalon allows cells to bypass the Hayflick limit, reducing premature replicative senescence.
Beyond telomere elongation, Epithalon plays a documented role in neuroendocrine regulation. In rodent models, administration of Epithalon restored nocturnal melatonin secretion, modulated gonadotropin production, and suppressed spontaneous tumor formation in aging cohorts. Researchers sourcing high-purity Epithalon 10mg utilize it primarily in long-term cellular senescence, oxidative stress, and circadian rhythm models.
Dihexa (N-hexanoic-Tyr-Ile-6-aminohexanoic amide) was developed as an orally bioavailable, blood-brain barrier-permeable analog of Angiotensin IV (Ang IV). Unlike traditional neuropeptides that bind directly to GPCRs, Dihexa operates by binding with high affinity ($K_d = 65\text{ pM}$) to Hepatocyte Growth Factor (HGF). This binding dimerizes HGF, allowing it to activate the c-Met receptor tyrosine kinase.
Activation of the HGF/c-Met axis initiates robust downstream signaling cascades, including the MAPK/ERK and PI3K/Akt pathways. Preclinical models demonstrate that Dihexa induces rapid spinogenesis and synaptogenesis in primary hippocampal neurons at picomolar concentrations. In vitro assays reveal that Dihexa is orders of magnitude more potent than Brain-Derived Neurotrophic Factor (BDNF) in stimulating dendritic arborization.
Because of its high affinity and structural stability, Dihexa is heavily investigated in neurodegenerative disease models, such as Alzheimer's, Parkinson's, and traumatic brain injury (TBI) assays. In animal studies, Dihexa administration demonstrated a capability to reverse pre-existing cognitive deficits by restoring functional synaptic connections rather than merely preventing further neuronal degradation.
Understanding the relative half-life and enzymatic stability of Epithalon vs Dihexa is critical for designing appropriate dosing intervals in animal models or cell culture replenishment cycles. Epithalon, as a unmodified linear tetrapeptide, is subject to rapid cleavage by systemic peptidases and endopeptidases. Pharmacokinetic evaluations in rodent plasma suggest an elimination half-life of less than 30 minutes following parenteral administration, requiring daily or pulse-dosing schedules in extended protocols.
Dihexa was specifically engineered to overcome the enzymatic susceptibility typical of short-chain peptides. The inclusion of an N-terminal hexanoyl group and a C-terminal aminohexanoic amide confers substantial resistance to proteolytic degradation. Consequently, Dihexa exhibits prolonged stability in plasma and culture conditions, maintaining c-Met activation over extended incubation periods.
For stable in vitro testing, researchers must store both compounds at -20°C or -80°C post-reconstitution to prevent hydrolysis. Before beginning experiments, laboratory technicians should verify chemical identity and purity via batch-specific certificate of analysis (COA) documentation.
Choosing between Epithalon and Dihexa depends entirely on the primary end-points of the study design. Each compound serves a distinct biological vector within experimental pharmacology:
- **Select Epithalon for:** Cellular senolytic/senomorphic assays, investigation of TERT transcription factors, chromatin remodeling assays, pineal melatonin synthesis models, and systemic longevity endpoints in aged rodent models. - **Select Dihexa for:** High-throughput neuronal culture assays measuring dendritic spine density, c-Met pathway phosphorylation protocols, synaptogenesis quantification, synaptic plasticity studies, and cognitive recovery tracking in neurological damage models.
In some multi-factorial aging protocols, researchers examine cross-talk between genomic stability pathways (targeted by Epithalon) and neurotrophic repair signaling (targeted by Dihexa). However, co-administration designs require carefully calibrated controls due to the vastly different solubility profiles and signaling kinetics of the two molecules. When preparing stock concentrations for either peptide, researchers can utilize our interactive reconstitution calculator to determine precise liquid volumes.
To contextualize Epithalon and Dihexa within broader biological research, it is useful to compare them against other peptides in the neurological and anti-aging literature. For example, while Dihexa focuses on c-Met mediated synaptogenesis, compounds such as Semax and Selank operate primarily through neurotrophin upregulation (BDNF/NGF) and GABAergic modulation, respectively. Researchers interested in neurovascular repair often compare Dihexa's potent trophic effects against the more localized action of these neuropeptides.
Similarly, when analyzing Epithalon's bioregulatory effects on telomeres and neuroendocrine output, researchers frequently compare it to CJC-1295 or GHRP-2, which act on the pituitary-somatotropic axis to stimulate GH secretion. While CJC-1295 regulates metabolic and anabolic signaling via systemic hormone release, Epithalon acts directly at the nucleolar level to influence transcription without driving classical hormone release pathways.
Because laboratory experiments require strict reproducibility, research peptides must adhere to stringent manufacturing and purity criteria. Impurities such as truncated peptide fragments, residual organic solvents, or bacterial endotoxins can confound cell culture assays and invalidate sensitive binding studies.
At PX1 Research, every batch of peptide undergoes rigorous testing within ISO 17025 accredited, GMP-compliant facilities in California and Arizona. We utilize High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS) to verify molecular weight and ensure chemical purity levels exceeding 99%. Furthermore, our products undergo chromogenic LAL assays to ensure endotoxin limits remain far below published threshold limits for cell culture models.
Principal investigators and procurement specialists seeking dedicated supply lines for institutional or corporate laboratories can access bulk terms and custom synthesis options through our wholesale laboratory portal. All shipments include lot-specific analytical documentation.
Proper handling during reconstitution is critical to maintaining structural integrity and preventing premature peptide degradation. Reconstitution procedures differ based on the hydrophilic nature of Epithalon versus the lipophilic tendencies of Dihexa:
1. **Epithalon Solubilization:** Lyophilized Epithalon is highly hydrophilic. Reconstitute under sterile laminar flow using Sterile Bacteriostatic Water or Phosphate-Buffered Saline (PBS, pH 7.4). Swirl gently; avoid high-speed vortexing to prevent shear stress on the peptide backbone. 2. **Dihexa Solubilization:** Due to hydrophobic side chains, Dihexa may exhibit limited solubility in pure water. Primary stock solutions are typically prepared using dimethyl sulfoxide (DMSO) or dilute acetic acid, before secondary dilution into working aqueous buffers. 3. **Storage:** Aliquot stock solutions into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles. Store lyophilized vials at -20°C and reconstituted aliquots at -80°C for long-term stability. Detailed technical parameters can be reviewed in our peptide research hub.
What is the key functional difference between Epithalon and Dihexa?
Epithalon is a synthetic tetrapeptide bioregulator studied primarily for telomerase activation, telomere length maintenance, and pineal gland modulation. Dihexa is an angiotensin IV-derived hexapeptide designed as a c-Met/HGF receptor agonist focused on spinogenesis and synaptogenesis.
How do the solubility profiles of Epithalon and Dihexa differ?
Epithalon is highly hydrophilic and dissolves readily in aqueous solutions such as sterile bacteriostatic water or PBS. Dihexa is more lipophilic and often requires organic solvents like DMSO or mild acidic solutions for complete dissolution before buffer dilution.
What is the half-life of Epithalon compared to Dihexa in vitro?
Epithalon has a short in vitro plasma half-life (~15 to 30 minutes) due to rapid cleavage by systemic endopeptidases. Dihexa contains N- and C-terminal modifications that render it highly resistant to enzymatic degradation, resulting in significantly greater metabolic stability.
What primary preclinical models use Dihexa?
Dihexa is primarily used in neurobiological research, including primary hippocampal culture assays, spinogenesis models, traumatic brain injury recovery studies, and animal models of neurodegenerative disease.
What primary preclinical models use Epithalon?
Epithalon is utilized in cellular aging and senescence research, telomerase induction assays, ROS/oxidative stress mitigation protocols, and long-term rodent longevity studies.
How does PX1 Research verify the purity of Epithalon and Dihexa?
PX1 Research subjects every batch to High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) in ISO 17025 accredited laboratory facilities to ensure a minimum purity threshold of 99%, accompanied by lot-specific COA documentation.
Can Epithalon and Dihexa be reconstituted using the same solvent?
Not always. While Epithalon easily dissolves in sterile bacteriostatic water, Dihexa often requires an initial DMSO stock solution due to its hydrophobic properties before step-down dilution into culture media.
Are Epithalon and Dihexa approved for human clinical use?
No. Both Epithalon and Dihexa are strictly classified as non-clinical research chemicals intended solely for in vitro laboratory evaluation and preclinical animal studies by qualified researchers.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.